Cartesian Therapeutics Inc. (NASDAQ: RNAC)
$17.98
+0.0600 ( +0.34% ) 189.8K
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Market Data
Open
$17.98
Previous close
$17.92
Volume
189.8K
Market cap
$384.83M
Day range
$17.76 - $18.79
52 week range
$11.67 - $41.87
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jul 05, 2024 |
4 | Insider transactions | 1 | Jul 03, 2024 |
3 | Insider transactions | 5 | Jul 03, 2024 |
8-k | 8K-related | 50 | Jul 02, 2024 |
8-k | 8K-related | 13 | Jun 17, 2024 |
8-k | 8K-related | 15 | May 22, 2024 |
8-k | 8K-related | 46 | May 08, 2024 |
10-q | Quarterly Reports | 107 | May 08, 2024 |
def | Proxies and info statements | 15 | Apr 26, 2024 |
8-k | 8K-related | 13 | Apr 22, 2024 |